Asan Medical center

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
2	Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib	Completed	Closed	Regorafenib (BAY 73-4506)	NCT02889328
1	A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors	Ongoing, but not recruiting	Closed	Cobimetinib + MPDL3280A	NCT01988896
1	(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors	Active, not recruiting	Closed	BLU-285	NCT02508532
	Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)	Completed	Closed	Nilotinib	NCT00976612
2	A Phase II Study of Oral Paclitaxel (Liporaxel) in GIST Patients With a Low P-glycoprotein Expression After Failure With Imatinib, Sunitinib and Regorafenib	Not yet recruiting	Not yet activated	Liporaxel	NCT06326346
1	Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors	Withdrawn	Not yet activated	Imatinib + Dovitinib	NCT02268435